These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reducing the "domino effect" of the metabolic syndrome. Freeman JS J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):inside front cover, S1-3. PubMed ID: 17784528 [No Abstract] [Full Text] [Related]
4. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896 [TBL] [Abstract][Full Text] [Related]
5. Impact of obesity on cardiovascular disease. Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700 [TBL] [Abstract][Full Text] [Related]
6. The progression of cardiovascular risk to cardiovascular disease. Rosin BL Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392 [TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome: implications of race and ethnicity. Mugo M; Sowers JR Ethn Dis; 2004; 14(4):S2-26-31. PubMed ID: 15724794 [TBL] [Abstract][Full Text] [Related]
11. Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Schroen B; Heymans S Cardiovasc Res; 2012 Mar; 93(4):605-13. PubMed ID: 21994347 [TBL] [Abstract][Full Text] [Related]
12. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923 [TBL] [Abstract][Full Text] [Related]
18. Obesity and the metabolic syndrome in the elderly--a mini-review. Lechleitner M Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025 [TBL] [Abstract][Full Text] [Related]
19. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases. Mavri A; Alessi MC; Juhan-Vague I J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879 [TBL] [Abstract][Full Text] [Related]
20. The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions. Montet-Abou K; Viallon M; Hyacinthe JN; Delattre B; Vallee JP; Didier D; Croisille P; Montet X Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S67-81. PubMed ID: 21151150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]